Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Clinical trial NCT02174432 · COMPLETED
Trial details
- NCT number
- NCT02174432
- Sponsor
- Trevi Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-15
- Primary completion
- 2017-09-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.